Arkema shares up 7.5% in a week following its third-quarter results
The specialty chemicals company rose following the publication of its third-quarter accounts, in a well-oriented Paris market. The stock has regained several technical benchmarks and is approaching a resistance zone that is being closely monitored.
Share price back above its three moving averages after the results
Arkema rises 2.16% to €59.10 intraday, while the CAC 40 gains 0.55%. The stock has regained its MA200, at €58.13, which is now 1.67% below the share price. It has also moved above its 30-session high, at €57.70, which has become a support.
The RSI at 69 is approaching the overbought zone after a 7.07% rise over the week. This move follows the publication of third-quarter EBITDA, at €332 million, up 7.0% year on year. This growth rests mainly on prices (+6.0%), while volumes rose only 0.6%. The EBITDA margin declined by 0.1 point, to 14.1%.
Stable nine-month figures and cautious guidance from management
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Over nine months, EBITDA was almost stable at €1,005.8 million, compared with €1,003.2 million a year earlier. Price increases made it possible to absorb the rise in energy and raw material costs.
Regarding the outlook, the company stated during this release: “We do not expect any improvement in external conditions in the coming months.”
The stock is up 9.75% over one month but still down 3.98% over three months. On the market side, Arkema ranks among the strongest gainers in the SBF 120, which is up 0.58%. The next technical level to watch is resistance at €65.20, about 10% above the current price.
« Nous ne prévoyons pas d'amélioration des conditions externes dans les prochains mois »
Outlook / guidance
Management commentary: « Arkema est en ligne avec son objectif de réaliser un EBITDA 2026 légèrement supérieur à l'an dernier à taux de change constants »
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
